XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Private Placement [Member]
Preferred Stock [Member]
Series A-1 Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Private Placement [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Series A-1 Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Private Placement [Member]
Retained Earnings [Member]
Series A-1 Preferred Stock [Member]
Retained Earnings [Member]
Private Placement [Member]
Series A-1 Preferred Stock [Member]
Total
Balance (in shares) at Dec. 31, 2022     60,961   522,177                  
Balance at Dec. 31, 2022         $ 8     $ 406,514     $ (402,376)     $ 4,146
Issuance of common stock in public offerings, net of commissions and issuance costs (in shares)     0   794                  
Issuance of common stock in public offerings, net of commissions and issuance costs     $ 0   $ 0     (21)     0     (21)
Exercise of pre-funded warrants for common stock (in shares)     0   49,858                  
Exercise of pre-funded warrants for common stock     $ 0   $ 1     (1)     0     0
Issuance of common stock upon vesting of restricted stock units (in shares)     0   2,294                  
Issuance of common stock upon vesting of restricted stock units         $ 0     0     0     0
Employee stock-based compensation     $ 0   0     245     0     245
Accretion of Series A preferred stock dividends     0   0     (1,218)     0     (1,218)
Net and comprehensive loss     $ 0   $ 0     0     (4,644)     (4,644)
Balance (in shares) at Mar. 31, 2023     60,961   575,123                  
Balance at Mar. 31, 2023         $ 9     405,519     (407,020)     (1,492)
Balance (in shares) at Dec. 31, 2023     62,881   1,279,928                  
Balance at Dec. 31, 2023     $ 0   $ 1     414,493     (420,696)     (6,202)
Issuance of common stock in public offerings, net of commissions and issuance costs (in shares) 7,224 10,000   75,327                    
Issuance of common stock in public offerings, net of commissions and issuance costs   $ 0   $ 0   $ 6,880 $ 0   $ 0 $ 0   $ 6,880 $ 0  
Employee stock-based compensation         0     1,096     0     1,096
Accretion of Series A preferred stock dividends     0   0     (65)     0     (65)
Net and comprehensive loss         0     0     (5,517)     (5,517)
Issuance of common stock warrants in connection with the Private Placement     $ 0   $ 0     127     0     127
Cancellation of Series A preferred stock (in shares)     (60,876)   0                  
Cancellation of Series A preferred stock     $ 0   $ 0     0     0     0
Issuance of common stock upon vesting of restricted stock awards (in shares)     0   368,503                  
Issuance of common stock upon vesting of restricted stock awards     $ 0   $ 1     0     0     1
Net share settlement of restricted stock awards in satisfaction of tax obligations (in shares)     0   (137,324)                  
Net share settlement of restricted stock awards in satisfaction of tax obligations     $ 0   $ 0     (374)     0     (374)
Balance (in shares) at Mar. 31, 2024     19,229   1,586,434                  
Balance at Mar. 31, 2024         $ 2     $ 422,157     $ (426,213)     $ (4,054)